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Background
The aim of the study was to establish the most common
dermatological manifestations in HIV hospitalized patients
and to correlate the status of cutaneous diseases in rela-
tion with the CD4 cell count.
Methods
During 01.12.2013-28.02.2014, 134 HIV-positive subjects
admitted to the hospital were enrolled, registering demo-
graphic data (age, gender, socioeconomic and educational
status), transmission route, WHO clinical stage of HIV,
laboratory parameters (CD4 count, viral load) and HIV
treatment regimen. All patients were screened for cuta-
neous diseases by a dermatologist.
Results
Out of total of 134 HIV-positive patients, 41 patients had
cutaneous manifestations, 28 were male (68.29%) and 13
female (31.70%). Most patients were in the age group
16-30 years (58.53%). The majority of patients belonged
to the urban area (65.85%) and had a low educational
and socioeconomic status (only 56.09% patients gradu-
ated secondary school; 82.92% of the patients were
unemployed).
The prevailing route of transmission was parenteral
(41.46%), most patients had stage C3 HIV disease
(56.09%), and only 24.39% of patients had undetectable
viral load. Most patients were undergoing ARV regimen
(80.48%), 12.19% were naive and 7.31% had ceased ther-
apy. 17 patients had 2 concomitant dermatological man-
ifestations (41.46%), while 13 were treated for only one
skin disease (31.70%); 19.51% patients were diagnosed
with 3 concurrent dermatological diseases and 7.31%
with 4 simultaneous skin disorders. The most common
HIV-related dermatological manifestations were oral
candidiasis (78.04%), seborrheic dermatitis (14.63%),
lipodystrophy (12.19%), tinea corporis (7.31%), herpes
zoster (4.87%), syphilis (4.87%) and cellulitis (4.87%).
CD4 counts ranged between 2-1551 cells/µL, with a
mean CD4 of 139 cells/µL. Oral candidiasis was corre-
lated with a mean CD4 count of 305 cells/µL, seborrheic
dermatitis was related to a mean CD4 of 233 cells/µL,
while lipodystrophy was associated with a mean CD4 of
202 cells/µL.
Conclusion
This study indicates a high prevalence of dermatological
manifestations in hospitalized HIV patients, occurring
more frequently with the progression of HIV to stage C3-
WHO and the decline of the immune function (CD4 <
500 cells/µL). Oral candidiasis and seborrheic dermatitis
are more common in HIV patients (78.04%, and 14.63%
respectively) than in the general population (10-30% and
3-5% respectively). Lipodystrophy is a frequent side effect
of long-term ARV treatment and/or a result of severe HIV
infection. Therefore, early diagnosis of skin diseases may
enhance the quality of life of HIV patients.
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